AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

iBio, Inc. Director's Dealing 2010

Aug 23, 2010

35045_dirs_2010-08-23_0c0901f0-4525-4070-b390-25354b04685a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBPM.OB)
CIK: 0001420720
Period of Report: 2010-08-20

Reporting Person: DESANTIS CARL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-20	Common Stock	P	63100	$1.8107	Acquired	4987641	Indirect

Footnotes

F1: Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc., of which the reporting person is a controlling person, (iii) 1,469,393 shares of common stock held by CD Financial, LLC (inclusive of the 63,100 newly-purchased shares of common stock that are the subject of this report), and (iv) 2,245,417 shares of common stock held by the DeSantis Revocable Trust.